It belongs to a class of medicines known as GLP-1 receptor agonists, which help control appetite and blood sugar
After nearly 10 years, Look AHEAD was stopped due to the lack of heart benefit
It belongs to a novel class of agents known as triple agonists, meaning it simultaneously activates three distinct hormone receptors: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor
References 1 AbbasT.FaivreE.HolscherC
Olanow CW, Brundin P (2013) Parkinsons disease and alpha synuclein: is Parkinsons disease a prion-like disorder
Clinical trials suggest an average weight loss of 5% to 10% over several months, though initial losses in the first month may be more modest